Skip to main content

Clinical Trialist Training Program

The Clinical Trialist Training Program (CTTP) is a joint initiative between SCTR, the MUSC College of Medicine, and the Hollings Cancer Center that provides 10% salary support (plus fringe) for one year of training to develop new site investigators for multicenter clinical trials. 

The goal of this program is to engage new clinical trialists who will develop a clinical trial portfolio and generate continued salary support beyond the year of training. This funding opportunity is open to College of Medicine & Hollings Cancer Center-affiliated faculty who are in departments that can support a clinical trial.

Eligibility

Eligible candidates are full-time clinical faculty (tenure or non-tenure track) in the College of Medicine at the rank of Associate Professor or lower. Participants must have a clinical doctoral degree and be board certified in a specialty. More details on eligibility requirements can be found in the RFA.

Program Training & Experience

The CTTP will provide didactic training and hands-on trial experience including:

  • Participation in a “Clinical Trials Bootcamp”
  • Quarterly “Meet the Expert” Didactic Sessions
  • Quarterly Progress Reviews and mentoring
  • Identification of multicenter trials in which to participate as the site PI
  • Feasibility and financial assessments; contract execution and IRB applications; and recruitment strategies, tools, and budgeting for the selected trials
  • Support of SCTR staff knowledge and resources

Recruitment

The 2025 - 2026 recruitment cycle closed on February 17, 2025.

2024-2025 Awardees

College of Medicine

Sonal Bhatia, MBBS
Department of Pediatrics
Specialty: Child Neurology, Epilepsy

Carmine Suppa, DO
Department of Pediatrics
Specialty: Pediatric Gastroenterology - Inflammatory Bowel Disease

Hollings

Anca Dumitriu, M.D.
Department of Pediatrics
Specialty: Pediatric Hematology/Oncology

Maggie Westfal, M.D., MPH
Department of Surgery
Specialty: Colorectal Surgery

Leadership

Andrew Goodwin,  M.D., MSCR

Section Chief, Critical Care
Medical Director, Medical Surgical Intensive Care Unit
Professor, College of Medicine
mail goodwian@musc.edu

Dr. Andrew Goodwin is a pulmonary intensivist committed to improving the health and well-being of critically ill patients through patient-centered care and clinical and translational research. His clinical interests include the hemodynamic management of septic shock and ventilation strategies for ARDS as well as strategies to mitigate ICU delirium. He also performs translational research focused on the potential role that micro RNA play in the endothelial dysfunction of sepsis and ARDS. In particular, he and his collaborators are focused on identifying the role that circulating miRNA have on endothelial cell gene expression and function and their potential use as a therapeutic in these syndromes. Additionally, he investigates the impact of patient factors such as race and comorbidities as well as hospital factors such as location and size on the outcomes of critical illness. His long-range goal is to improve the outcomes of critically ill patients through new therapeutics and optimal bedside care.

Diana Lee-Chavarria, MA

Workforce Training & Development Manager
mail leeachar@musc.edu